Jeffrey Fink
Director/Board Member bei LIPOCINE INC.
Vermögen: 2 007 $ am 31.03.2024
Profil
Jeffrey Arvin Fink is an Independent Director at Lipocine, Inc. and a Director at Navigen, Inc. He is also the Managing Director at Gambel Oaks Advisors LLC.
Previously, he worked as a Director at Progenitor, Inc., a Partner at Dresdner Kleinwort Securities LLC, the Head-Mergers & Acquisitions at Prudential Vector Healthcare Group, and the Head-Healthcare Investment Banking at Robert W.
Baird & Co., Inc. Fink holds an undergraduate degree from Kalamazoo College and an MBA from the University of Michigan.
Bekannte Unternehmensbeteiligungen
Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
---|---|---|---|---|
LIPOCINE INC
0,01% | 31.03.2024 | 386 ( 0,01% ) | 2 007 $ | 31.03.2024 |
Aktive Positionen von Jeffrey Fink
Unternehmen | Position | Beginn |
---|---|---|
LIPOCINE INC. | Director/Board Member | 06.01.2014 |
Gambel Oaks Advisors LLC | Corporate Officer/Principal | 01.01.2010 |
Navigen, Inc.
Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT. | Director/Board Member | - |
Ehemalige bekannte Positionen von Jeffrey Fink
Unternehmen | Position | Ende |
---|---|---|
Robert W. Baird & Co., Inc.
Robert W. Baird & Co., Inc. Investment ManagersFinance Robert W. Baird & Co., Inc. operates as a wealth management, capital markets, private equity and asset management firm. It offers equity research, corporate restructuring, mergers and acquisitions, public financing and fixed income services. The firm serves individual, corporate, institutional and municipal clients. The company was founded by Robert Wilson Baird in 1919 and is headquartered in Milwaukee, WI. | Corporate Officer/Principal | 01.01.2007 |
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | Director/Board Member | - |
Prudential Vector Healthcare Group | Corporate Officer/Principal | - |
Dresdner Kleinwort Securities LLC
Dresdner Kleinwort Securities LLC Investment Banks/BrokersFinance Dresdner Kleinwort Securities LLC is a broker/dealer located in New York City. They are a subsidiary of Dresdner Kleinwort Wasserstein and their ultimate parent is Commerzbank AG | Corporate Officer/Principal | - |
Ausbildung von Jeffrey Fink
Kalamazoo College | Undergraduate Degree |
University of Michigan | Masters Business Admin |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Private Unternehmen | 7 |
---|---|
Progenitor, Inc.
Progenitor, Inc. BiotechnologyHealth Technology Progenitor, Inc. is an American private company. The firm develops pharmaceutical compounds for nervous system. The company is headquartered in Columbus, OH. | Health Technology |
Dresdner Kleinwort Securities LLC
Dresdner Kleinwort Securities LLC Investment Banks/BrokersFinance Dresdner Kleinwort Securities LLC is a broker/dealer located in New York City. They are a subsidiary of Dresdner Kleinwort Wasserstein and their ultimate parent is Commerzbank AG | Finance |
Prudential Vector Healthcare Group | Finance |
Robert W. Baird & Co., Inc.
Robert W. Baird & Co., Inc. Investment ManagersFinance Robert W. Baird & Co., Inc. operates as a wealth management, capital markets, private equity and asset management firm. It offers equity research, corporate restructuring, mergers and acquisitions, public financing and fixed income services. The firm serves individual, corporate, institutional and municipal clients. The company was founded by Robert Wilson Baird in 1919 and is headquartered in Milwaukee, WI. | Finance |
Lipocine, Inc. | |
Navigen, Inc.
Navigen, Inc. Pharmaceuticals: MajorHealth Technology Navigen, Inc. operates as a drug discovery and development company. The company was founded by Hunter Jackson and is headquartered in Salt Lake City, UT. | Health Technology |
Gambel Oaks Advisors LLC |